England · Pharmacy First · Open access
Pharmacy First pathways
Seven current pathways, free to open in CRx Workspace. Read the inclusion and exclusion summaries, then open the interactive pathway. No account or payment card needed.
About these summaries
Selected pathway criteria and referral exclusions are summarised below. PGD-only medicine supply exclusions are labelled separately. Read the full official pathway and medicine-specific PGD or protocol, including urgent referral criteria.
A consultation does not automatically mean a medicine can be supplied. The wider minor-illness referral service has separate criteria.
Seven current pathways
Free · no login
Summaries checked against NHS England clinical pathways v2.5 on 22 October 2026. These summaries are not a complete eligibility or referral checklist.
-
Uncomplicated UTI
Urinary symptoms and important mimics.
Inclusion- Women aged 16 to under 65 years.
- Suspected lower UTI.
Exclusions- Diabetes, pregnancy or a urinary catheter.
- Recurrent UTI: 2 episodes in 6 months or 3 in 12 months.
- Possible kidney infection: urgent onward assessment.
- PGD 1a supply: current breastfeeding is excluded; additional sex/anatomy criteria apply.
Medicines & PGDs — Uncomplicated UTI
Check each linked document for full medicine-specific eligibility and exclusions.
- Nitrofurantoin · PGD 1a · v1.3 (PDF)
-
Acute sore throat
Throat symptoms and reassessment.
Inclusion- 5 years and over.
- Signs and symptoms of acute sore throat.
Exclusions- Pregnancy in individuals under 16 years.
- Suspected serious throat illness, head/neck cancer or immunosuppression: onward referral.
- PGD supply: previous tonsillectomy.
- PGD supply: recurrent sore throat/tonsillitis — 7+ significant episodes in 12 months, 5+ a year in each of the preceding 2 years, or 3+ a year in each of the preceding 3 years.
Medicines & PGDs — Acute sore throat
Check each linked document for full medicine-specific eligibility and exclusions.
- Phenoxymethylpenicillin (penicillin V) · PGD 5a · v1.1 (PDF)
- Clarithromycin · PGD 5b · v1.1 (PDF)
- Erythromycin · PGD 5c · v1.1 (PDF)
-
Acute sinusitis
Facial and nasal symptoms.
Inclusion- 12 years and over.
- Signs and symptoms of acute sinusitis.
- Symptoms lasting 10 days or less follow the self-care branch.
Exclusions- Immunosuppression.
- Chronic sinusitis: symptoms lasting more than 12 weeks.
- Pregnancy in individuals under 16 years.
- PGD supply: recurrent sinusitis — 4+ episodes a year, with symptom-free intervals.
- Eye/orbital or neurological complications: urgent onward assessment.
Medicines & PGDs — Acute sinusitis
Check each linked document for full medicine-specific eligibility and exclusions.
- Fluticasone furoate · PGD 6a · v1.1 (PDF)
- Mometasone furoate monohydrate · PGD 6b · v1.1 (PDF)
- Phenoxymethylpenicillin (penicillin V) · PGD 6c · v1.1 (PDF)
- Clarithromycin · PGD 6d · v1.1 (PDF)
- Doxycycline · PGD 6e · v1.1 (PDF)
- Erythromycin · PGD 6f · v1.1 (PDF)
-
Acute otitis media
Middle-ear symptoms in children.
Inclusion- Children aged 1 to 17 years.
- Signs and symptoms of acute otitis media.
Exclusions- Pregnancy in individuals under 16 years.
- Recurrent acute otitis media: 3+ episodes in 6 months or 4+ in 12 months.
- Systemically very unwell, serious illness or high risk of complications: onward referral.
Medicines & PGDs — Acute otitis media
Check each linked document for full medicine-specific eligibility and exclusions.
- Phenazone / lidocaine hydrochloride · PGD 7a · v1.1 (PDF)
- Amoxicillin · PGD 7b · v1.1 (PDF)
- Clarithromycin · PGD 7c · v1.1 (PDF)
- Erythromycin · PGD 7d · v1.1 (PDF)
-
Shingles
Rash pattern and complications.
Inclusion- 18 years and over.
- Suspected shingles.
- Antiviral eligibility has separate additional criteria within 72 hours and later up to 7 days after rash onset.
Exclusions- Pregnancy.
- Head/neck or eye involvement, serious complications or severe immunosuppression: onward assessment.
- Immunosuppression with severe/widespread rash or systemic illness: onward assessment.
- PGD supply: breastfeeding with shingles lesions on the breast.
Medicines & PGDs — Shingles
Check each linked document for full medicine-specific eligibility and exclusions.
- Aciclovir · PGD 2a · v1.1 (PDF)
- Valaciclovir · PGD 2b · v1.1 (PDF)
-
Impetigo
Crusted skin lesions and spread.
Inclusion- 1 year and over.
- Non-bullous impetigo: localised (3 or fewer lesions/clusters) or widespread (4 or more).
Exclusions- Bullous impetigo; pregnancy in individuals under 16 years.
- Recurrent impetigo: 2 or more episodes in the same year.
- Suspected deeper infection or serious illness: onward assessment.
- PGD/protocol supply: breastfeeding with impetigo lesions on the breast.
Medicines & PGDs — Impetigo
Check each linked document for full medicine-specific eligibility and exclusions.
- Hydrogen peroxide · Protocol 3a · v1.1 (PDF)
- Fusidic acid · PGD 3b · v1.0 (PDF) Expires 30 January 2027.
- Flucloxacillin · PGD 3c · v1.1 (PDF)
- Clarithromycin · PGD 3d · v1.1 (PDF)
- Erythromycin · PGD 3e · v1.1 (PDF)
-
Infected insect bites
Skin symptoms after bites and stings.
Inclusion- 1 year and over.
- Signs and symptoms of an infected insect bite or sting.
- Antibiotic eligibility includes a check that at least 48 hours have passed since the initial bite/sting.
Exclusions- Pregnancy in individuals under 16 years.
- Human/animal bites, possible Lyme disease, unusual/exotic insects, or travel-related bites with concern about insect-borne disease: onward referral.
- Systemically unwell, severe pain out of proportion, pus collection or complicating comorbidity: onward referral.
Medicines & PGDs — Infected insect bites
Check each linked document for full medicine-specific eligibility and exclusions.
- Flucloxacillin · PGD 4a · v1.1 (PDF)
- Clarithromycin · PGD 4b · v1.1 (PDF)
- Erythromycin · PGD 4c · v1.1 (PDF)
Medicine documents checked on 22 October 2026 against the NHS England service index. PGDs and the hydrogen peroxide protocol have their own versions and validity dates. CPE medicines list (October 2025) is a cross-check; the linked NHS documents govern supply.
Awaiting official pathway publication
The five prescribing additions below have been announced. CPE’s update of 21 October 2026 says NHS England is finalising the pathways. CRx versions are not available yet; we’ll build them once the official pathways are published.
-
Acute otitis externa
Awaiting publication
-
Seasonal allergic rhinitis
Awaiting publication
-
Mild to moderate acne
Awaiting publication
-
Low-frequency episodic migraine
Awaiting publication
-
Mild skin and soft-tissue infections and scabies
Awaiting publication
Skin and soft-tissue infections and scabies form one announced pathway. Read the NHS England announcement. Publication status checked 22 October 2026; no CRx release date is confirmed.
Explore the wider clinical library
Move beyond Pharmacy First with Premium. The CRx library spans over 900 clinical topics; available formats vary by topic.
Use Clinical Maps for a visual overview, Clinical Assessment for history and examination, Knowledge Base for clinical reference and Foundations for the underlying science.
These seven pathways stay free. Ask AI and Tutor AI are Premium prompt builders for external AI services; external subscriptions are separate.

